Greenwich LifeSciences, Inc. logo

GLSI Earnings Date: Nov 13, 2026 (Estimated) — Greenwich LifeSciences, Inc.

NASDAQ · Healthcare · Biotechnology

Updated

Price $18.45
Market Cap $270.7M
P/E -10.4
52W Range $7.78 – $34.10
Next Earnings · After close (est.)

When is GLSI's next earnings date?

Greenwich LifeSciences, Inc. (GLSI) is expected to report Q3 2026 earnings on Friday, November 13, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.30.

How did GLSI do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Greenwich LifeSciences, Inc. posted EPS of -$0.27 versus the -$0.33 estimate, a beat of 18.2%. Revenue was $0. The stock's 1-day post-earnings move was +8.8%.

How much does GLSI stock move after earnings?

GLSI beat EPS estimates in 4 of its last 6 reported quarters. Over the last 8 reports the stock moved an average of 5.5% (up or down) in the day after earnings.

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.33-0.27+18.18%$0✅ Beat+8.81%+11.00%-3.15%
2026-06-03Q1 2026-0.35-0.39-11.43%$0❌ Miss-2.55%-8.97%-15.85%
2026-06-01Q4 2025-0.32-0.58-81.25%$0❌ Miss-14.80%-24.06%-16.87%
2025-11-14Q3 2025-0.32-0.30+6.25%$0✅ Beat-1.08%-2.04%+25.00%
2025-04-15Q4 2024—-0.61—$0—-1.23%+10.06%+8.27%
2024-11-14Q3 2024-0.21-0.20+4.76%$0✅ Beat-7.58%-4.56%-5.08%
2024-08-14Q2 2024—-0.20—$0—+4.54%+13.93%+14.93%
2024-05-20Q1 2024-0.20-0.19+5.00%$0✅ Beat+3.52%+0.84%+16.97%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .